STOCK TITAN

EXL earns dual Leader recognition in ISG’s 2026 Healthcare AI Report, cited for moving AI from pilots to enterprise scale

(Neutral)
(Positive)
Tags
AI

EXL (NASDAQ: EXLS) has been named a Leader in both the Healthcare AI Strategy and Advisory Services and Healthcare AI Development and Delivery Services quadrants of the ISG Provider Lens AI Services in Healthcare Global 2026 report. ISG highlights EXL’s ability to embed AI into healthcare workflows, integrating across claims, care coordination and core payer functions, with a focus on measurable ROI and governance-driven, transaction-capable agentic architectures.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

An AI-tagged EXLS event produced a 0.87% 24-hour move on June 12, while peer G was up 4.78% at gener...
Analysis

An AI-tagged EXLS event produced a 0.87% 24-hour move on June 12, while peer G was up 4.78% at generation. The platform record adds mixed comparables; recent insider Net Selling was a risk to monitor.

Key Figures

Leader recognitions: 2
1 metrics
Leader recognitions 2 ISG 2026 Healthcare AI Report quadrants

Previous AI Reports

5 past events · Latest: Jun 17 (Positive)
Same Type Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 17 AI progress study Positive -3.2% Study highlighted AI Leaders' revenue, cost, and margin improvements.
Jun 12 AI collaboration Positive +0.9% Databricks collaboration targeted trusted data foundations and responsible AI scaling.
Jun 04 AI platform integration Positive -0.2% NVIDIA workflow integration targeted fraud, risk, and transaction intelligence applications.
Mar 16 AI platform expansion Positive +3.2% NVIDIA collaboration added frameworks, GPU acceleration, and governance tools.
Mar 11 AI solution launch Positive -0.6% New agentic AI solutions targeted enterprise transformation across the AI value chain.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

EXLS's AI-related announcements produced mixed historical reactions, with 2 aligned gains and 3 divergences despite generally positive announcement content.

Key Terms

roi, agentic architecture
2 terms
roi financial
"all anchored to measurable ROI"
Return on investment (ROI) measures how much money an investor makes or loses relative to the amount they put in, expressed as a percentage. It helps compare the efficiency of different investments—like checking which of several gardens produced the most fruit for the seeds planted—so investors can decide which opportunities deliver the best payoff for the risk and capital they commit.
View in glossary
agentic architecture technical
"The report specifically cited EXL's agentic architecture"
A design for software or systems that puts autonomous “agents” — software pieces that sense, decide and act — at the center of how tasks are carried out. For investors, it signals technology that can run complex decisions with less human oversight, similar to a team of trained employees each handling different tasks; that can mean faster execution, lower labor needs, new revenue opportunities, and different operational or regulatory risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, announced it has been recognized as a Leader in both the Healthcare AI Strategy and Advisory Services and Healthcare AI Development and Delivery Services quadrants of the ISG Provider Lens® AI Services in Healthcare Global 2026 report. The dual recognition reflects EXL’s ability to help healthcare organizations move beyond AI experimentation and into enterprise-scale transformation with measurable business outcomes.

EXL earned this recognition in both categories for its ability to embed AI directly into healthcare workflows. Rather than treating AI as a standalone capability, EXL’s solutions integrate the technology across claims, care coordination and core payer functions, all anchored to measurable ROI. The report specifically cited EXL's agentic architecture for its ability to deploy transaction-capable systems that connect organizational policies, codes and patient data to reduce patient risk, monitor costs and eliminate biases—all within specific governance frameworks.

“As AI continues to become entrenched in the healthcare industry, providers and payers alike are grappling with the best ways to use it to unlock the most efficient processes and arrive at the best health outcomes for their patients,” said Vivek Jetley, EXL president and head of healthcare, life sciences and insurance. “At EXL, we are proud to continue to help our clients navigate this evolving landscape and find new innovative ways to thrive.”

“EXL embeds AI directly into healthcare workflows, delivering measurable operational impact through a strong combination of domain expertise, data capabilities and execution-led transformation,” said Rohan Sinha, ISG Provider Lens. “This is the key to translating AI from concept to operational reality in healthcare.”

ISG Provider Lens is a practitioner-led service provider comparison, powered by ISG’s advisory experience and data-driven research. ISG’s research reports provide independent vendor evaluations and enterprise buying behavior segmentation. Provider positioning is based on neutral and independent research, such as quantitative data that includes provider surveys, product testing and customer interviews.

Read the report to see how EXL compares to its competition. For more information about EXL’s solutions for the healthcare industry, click here.

About EXL

EXL (NASDAQ: EXLS) is a global data and AI company that offers services and solutions to reinvent client business models, drive better outcomes and unlock growth with speed. EXL harnesses the power of data, AI, and deep industry knowledge to transform businesses, including the world's leading corporations in industries including insurance, healthcare, banking and capital markets, retail, communications and media, and energy and infrastructure, among others. EXL was founded in 1999 with the core values of innovation, collaboration, excellence, integrity and respect. We are headquartered in New York and have approximately 68,000 employees spanning six continents. For more information, visit www.exlservice.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to EXL's operations and business environment, all of which are difficult to predict and many of which are beyond EXL’s control. Forward-looking statements include information concerning EXL’s possible or assumed future results of operations, including descriptions of its business strategy. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of management's experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although EXL believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect EXL’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors, which include our ability to maintain and grow client demand, our ability to hire and retain sufficiently trained employees, and our ability to accurately estimate and/or manage costs, rising interest rates, rising inflation and recessionary economic trends, are discussed in more detail in EXL’s filings with the Securities and Exchange Commission, including EXL’s Annual Report on Form 10-K. You should keep in mind that any forward-looking statement made herein, or elsewhere, speaks only as of the date on which it is made. New risks and uncertainties come up from time to time, and it is impossible to predict these events or how they may affect EXL. EXL has no obligation to update any forward-looking statements after the date hereof, except as required by federal securities laws.

Contact:
Keith Little
Head of Public Relations
media.relations@exlservice.com  


FAQ

What recognition did EXL (NASDAQ: EXLS) receive in the ISG Healthcare AI 2026 report?

EXL was recognized as a Leader in two quadrants of ISG’s AI Services in Healthcare Global 2026 report. According to EXL, it leads in Healthcare AI Strategy and Advisory Services and Healthcare AI Development and Delivery Services.

Why was EXL named a Leader in Healthcare AI Strategy and Advisory Services in 2026?

EXL was cited for helping healthcare organizations move from AI experimentation to enterprise-scale transformation with measurable outcomes. According to EXL, its approach embeds AI into workflows and anchors initiatives to ROI and operational impact.

How does EXL’s healthcare AI approach differ from standalone AI tools for EXLS investors?

EXL positions AI as embedded within healthcare workflows rather than as a standalone capability. According to EXL, its solutions integrate AI across claims, care coordination and payer functions, all guided by measurable ROI and governance frameworks.

What is EXL’s agentic architecture mentioned in the ISG Healthcare AI Global 2026 report?

EXL’s agentic architecture supports transaction-capable AI systems that link policies, codes and patient data. According to EXL, this helps reduce patient risk, monitor costs and address biases within defined governance frameworks for healthcare clients.

What operational benefits does EXL claim its healthcare AI solutions deliver?

EXL indicates its AI solutions deliver measurable operational impact for healthcare payers and providers. According to EXL, benefits come from combining domain expertise, data capabilities and execution-led transformation to translate AI concepts into operational reality.

What is the ISG Provider Lens and how does it evaluate companies like EXL (EXLS)?

ISG Provider Lens is a practitioner-led service provider comparison based on neutral, data-driven research. According to EXL, provider positioning uses quantitative data, surveys, product testing and customer interviews to evaluate vendors and segment enterprise buying behavior.